UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 200

Sortiert nach

Combination of Enzastaurin and Ibrutinib synergistically induces anti-tumor effects in diffuse large B cell lymphoma

Journal of experimental & clinical cancer research, 2019-02, Vol.38 (1), p.86-16, Article 86

2019

Volltextzugriff (PDF)

Addition of BTK inhibitor orelabrutinib to rituximab improved anti-tumor effects in B cell lymphoma

Molecular therapy. Oncolytics, 2021-06, Vol.21, p.158-170

2021

Volltextzugriff (PDF)

Different situations of identifying second primary malignant tumors in lymphoma patients with synchronous solid tumors

Cancer medicine (Malden, MA), 2023-04, Vol.12 (7), p.8038-8049

2023

Volltextzugriff (PDF)

The Serum- and Glucocorticoid-Inducible Kinase 1 (SGK1) as a Novel Therapeutic Target in Mantle Cell Lymphoma

Cancer control, 2022-01, Vol.29, p.10732748221143881-10732748221143881

2022

Volltextzugriff (PDF)

ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma

Cancer cell international, 2019-02, Vol.19 (1), p.32-19, Article 32

2019

Volltextzugriff (PDF)

The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma

Journal of hematology and oncology, 2018-03, Vol.11 (1), p.43-13, Article 43

2018

Volltextzugriff (PDF)

Optimization of MgO/Al2O3 ratio for the maximization of active site densities in the Ni2P/MgAlO catalysts for the hydrotreating reactions

Journal of energy chemistry, 2016-07, Vol.25 (4), p.571-576

2016

Volltextzugriff (PDF)

TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP

BMC cancer, 2017-11, Vol.17 (1), p.743-7, Article 743

2017

Volltextzugriff (PDF)

EP300 single nucleotide polymorphism rs20551 correlates with prolonged overall survival in diffuse large B cell lymphoma patients treated with R-CHOP

Cancer cell international, 2017-07, Vol.17 (1), p.70-70, Article 70

2017

Volltextzugriff (PDF)

Analysis of genetic variants of the poly(ADP-ribose) polymerase-1 gene in breast cancer in French patients

Mutation research, 2007-08, Vol.632 (1), p.20-28

2007

Volltextzugriff (PDF)

PI3K inhibitor idelalisib enhances the anti-tumor effects of CDK4/6 inhibitor palbociclib via PLK1 in B-cell lymphoma

Cancer letters, 2024-08, Vol.597, p.216996, Article 216996

2024

Volltextzugriff (PDF)

Germline variants of DNA repair genes in early onset mantle cell lymphoma

Oncogene, 2021-01, Vol.40 (3), p.551-563

2021

Volltextzugriff (PDF)

Germline variants of DNA repair and immune genes in lymphoma from lymphoma-cancer families

International journal of cancer, 2024-07, Vol.155 (1), p.93-103

2024

Volltextzugriff (PDF)

The mTOR kinase inhibitor everolimus synergistically enhances the anti‐tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS‐123 on Mantle cell lymphoma

International journal of cancer, 2018-01, Vol.142 (1), p.202-213

2018

Volltextzugriff (PDF)

Combination of Enzastaurin and Ibrutinib Synergistically Induces Anti-Tumor Effects in Diffuse Large B Cell Lymphoma

Blood, 2018-11, Vol.132 (Supplement 1), p.1666-1666

2018

Volltextzugriff (PDF)

Survival and prognostic analysis of T-cell lymphoblastic lymphoma patients treated with dose-adjusted BFM-90 regimen

Aging (Albany, NY.), 2022-04, Vol.14 (7), p.3203-3215

2022

Volltextzugriff (PDF)

The Proto-Oncogene Mer Is a Novel Therapeutic Target in Mantle Cell Lymphoma

Blood, 2017-12, Vol.130, p.5138-5138

2017

Volltextzugriff (PDF)

Ibrutinib combined with low‐dose histone deacetylases inhibitor chidamide synergistically enhances the anti‐tumor effect in B‐cell lymphoma

Hematological oncology, 2022-12, Vol.40 (5), p.894-905

2022

Volltextzugriff (PDF)

CD275-Independent IL-17-Producing T Follicular Helper-like Cells in Lymphopenic Autoimmune-Prone Mice

The Journal of immunology (1950), 2016-06, Vol.196 (12), p.4935-4946

2016

Volltextzugriff (PDF)

The Intracellular TCR Signaling Pathway As a Novel Therapeutic Target in AITL Patients

Blood, 2017-12, Vol.130, p.1461-1461

2017

Volltextzugriff (PDF)

Optimization of MgO/Al 2 O 3 ratio for the maximization of active site densities in the Ni 2 P/MgAlO catalysts for the hydrotreating reactions

Journal of energy chemistry, 2016-07, Vol.25 (4), p.571-576

2016

Volltextzugriff (PDF)

PARP1 Val762Ala polymorphism reduces enzymatic activity

Biochemical and biophysical research communications, 2007-03, Vol.354 (1), p.122-126

2007

Volltextzugriff (PDF)

CD275/ICOSL-independent germinal centers and autoantibody in autoimmune-prone RasGRP1-deficient mice (BA13P.125)

The Journal of immunology (1950), 2014-05, Vol.192 (1_Supplement), p.177-177.11

2014

Volltextzugriff (PDF)

Role of the TRPC4 proline rich region in regulation of the endothelial store‐operated calcium entry

The FASEB journal, 2012-04, Vol.26 (S1)

2012

Volltextzugriff (PDF)

1 – 25 von 200

Suche als RSS-Feed

Aktive Filter

SpracheChinesisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(182)
Mit Volltextzugriff
(194)

Publikationsform

Sprache

Englisch
(198)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Science & Technology
(143)
Technology
(85)
Physical Sciences
(82)
Chemistry
(58)
Materials Science
(46)
Life Sciences & Biomedicine
(45)
Materials Science, Multidisciplinary
(42)
Instruments & Instrumentation
(34)
Chemistry, Analytical
(31)
Electrochemistry
(31)
Sensors
(30)
Science & Technology - Other Topics
(27)
Nanoscience & Nanotechnology
(24)
Gas Sensors
(23)
Chemistry, Physical
(21)
Physics
(21)
Physics, Applied
(21)
Humans
(18)
Animals
(15)
Ethanol
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Combination of Enzastaurin and Ibrutinib synergistically induces anti-tumor effects in diffuse large B cell lymphoma

Addition of BTK inhibitor orelabrutinib to rituximab improved anti-tumor effects in B cell lymphoma

Different situations of identifying second primary malignant tumors in lymphoma patients with synchronous solid tumors

The Serum- and Glucocorticoid-Inducible Kinase 1 (SGK1) as a Novel Therapeutic Target in Mantle Cell Lymphoma

ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma

The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma

Optimization of MgO/Al2O3 ratio for the maximization of active site densities in the Ni2P/MgAlO catalysts for the hydrotreating reactions

TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP

EP300 single nucleotide polymorphism rs20551 correlates with prolonged overall survival in diffuse large B cell lymphoma patients treated with R-CHOP

Analysis of genetic variants of the poly(ADP-ribose) polymerase-1 gene in breast cancer in French patients

PI3K inhibitor idelalisib enhances the anti-tumor effects of CDK4/6 inhibitor palbociclib via PLK1 in B-cell lymphoma

Germline variants of DNA repair genes in early onset mantle cell lymphoma

Germline variants of DNA repair and immune genes in lymphoma from lymphoma-cancer families

The mTOR kinase inhibitor everolimus synergistically enhances the anti‐tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS‐123 on Mantle cell lymphoma

Combination of Enzastaurin and Ibrutinib Synergistically Induces Anti-Tumor Effects in Diffuse Large B Cell Lymphoma

Survival and prognostic analysis of T-cell lymphoblastic lymphoma patients treated with dose-adjusted BFM-90 regimen

The Proto-Oncogene Mer Is a Novel Therapeutic Target in Mantle Cell Lymphoma

Ibrutinib combined with low‐dose histone deacetylases inhibitor chidamide synergistically enhances the anti‐tumor effect in B‐cell lymphoma

CD275-Independent IL-17-Producing T Follicular Helper-like Cells in Lymphopenic Autoimmune-Prone Mice

The Intracellular TCR Signaling Pathway As a Novel Therapeutic Target in AITL Patients

Optimization of MgO/Al 2 O 3 ratio for the maximization of active site densities in the Ni 2 P/MgAlO catalysts for the hydrotreating reactions

PARP1 Val762Ala polymorphism reduces enzymatic activity

CD275/ICOSL-independent germinal centers and autoantibody in autoimmune-prone RasGRP1-deficient mice (BA13P.125)

Role of the TRPC4 proline rich region in regulation of the endothelial store‐operated calcium entry

Simultaneous Global Phase I Studies of a Differentiated BTK Inhibitor, Dtrmwxhs-12, in Relapsed/Refractory Patients with Chronic Lymphocytic Leukemia and B-Cell Lymphomas

Aktive Filter

Suchergebnisse filtern